Perrigo Company plc (PRGO) – What Are Brokerages Saying About This Stock?

Perrigo Company plc (NYSE:PRGO) has been given a consensus recommendation of “Hold” by the six analysts that are presently covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, four have issued a hold recommendation and one has assigned a buy recommendation to the company. The average twelve-month target price among brokers that have issued ratings on the stock in the last year is $19.33.

Several equities research analysts have recently issued reports on PRGO shares. Wall Street Zen lowered shares of Perrigo from a “strong-buy” rating to a “buy” rating in a research note on Sunday, September 27th. Weiss Ratings upgraded Perrigo from a “sell (d-)” rating to a “sell (d)” rating in a research report on Thursday, August 6th.

Perrigo Price Performance

NYSE:PRGO opened at $16.06 on Tuesday. The company has a debt-to-equity ratio of 1.31, a current ratio of 2.32 and a quick ratio of 1.32. The firm has a market cap of $2.23 billion, a price-to-earnings ratio of -1.28, a price-to-earnings-growth ratio of 1.90 and a beta of 0.69. The company has a 50 day moving average price of $14.34 and a 200-day moving average price of $12.13. Perrigo has a 1-year low of $9.23 and a 1-year high of $22.02.

Perrigo (NYSE:PRGO) last announced its quarterly earnings results on Wednesday, August 5th. The company reported $0.50 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.39 by $0.11. The firm had revenue of $1.02 billion for the quarter, compared to the consensus estimate of $1.02 billion. Perrigo had a negative net margin of 41.85% and a positive return on equity of 11.25%. The firm’s quarterly revenue was down 3.1% compared to the same quarter last year. During the same period in the prior year, the firm posted ($0.06) earnings per share. Perrigo has set its FY 2026 guidance at 2.250-2.550 EPS. Equities research analysts forecast that Perrigo will post 2.18 EPS for the current year.

Perrigo Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 15th. Investors of record on Friday, August 28th were issued a $0.29 dividend. The ex-dividend date of this dividend was Friday, August 28th. This represents a $1.16 dividend on an annualized basis and a yield of 7.2%. Perrigo’s dividend payout ratio is presently -9.27%.

Hedge Funds Weigh In On Perrigo

A number of hedge funds have recently bought and sold shares of PRGO. Bank of America Corp DE lifted its holdings in Perrigo by 25.5% during the first quarter. Bank of America Corp DE now owns 1,568,598 shares of the company’s stock valued at $16,847,000 after purchasing an additional 318,248 shares in the last quarter. Gamco Investors INC. ET AL increased its stake in shares of Perrigo by 29.7% during the first quarter. Gamco Investors INC. ET AL now owns 1,397,866 shares of the company’s stock worth $15,013,000 after purchasing an additional 320,081 shares in the last quarter. Diamond Hill Capital Management LLC Investment Advisor purchased a new stake in shares of Perrigo during the second quarter worth about $4,066,000. Empowered Funds LLC increased its stake in shares of Perrigo by 41.6% during the first quarter. Empowered Funds LLC now owns 511,872 shares of the company’s stock worth $5,498,000 after purchasing an additional 150,438 shares in the last quarter. Finally, Gabelli Funds LLC raised its position in shares of Perrigo by 29.8% during the 1st quarter. Gabelli Funds LLC now owns 893,359 shares of the company’s stock worth $9,595,000 after purchasing an additional 205,311 shares during the last quarter. Hedge funds and other institutional investors own 95.91% of the company’s stock.

About Perrigo

Perrigo Company plc (NYSE: PRGO) is a global consumer self-care company that develops, manufactures and sells over-the-counter (OTC) health and wellness products. Its portfolio includes products for pain relief, allergy and cold relief, digestive health, sleep support, skin care, women’s health and oral care. Perrigo supplies both its own brands and retailer-owned store brands.

The company markets products under a range of brand names, including Compeed, ACO, ellaOne and other regional brands, while also producing private-label alternatives to widely used consumer health products.